Puma Biotechnology, Inc.
PBYI
$5.25
$0.030.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.97% | -22.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.97% | -22.12% | |||
| Cost of Revenue | 16.53% | -24.17% | |||
| Gross Profit | 13.21% | -21.49% | |||
| SG&A Expenses | 2.52% | 5.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.99% | -8.07% | |||
| Operating Income | 66.57% | -70.19% | |||
| Income Before Tax | 88.71% | -73.30% | |||
| Income Tax Expenses | 5.80% | 104.15% | |||
| Earnings from Continuing Operations | 96.87% | -84.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 96.87% | -84.59% | |||
| EBIT | 66.57% | -70.19% | |||
| EBITDA | 38.63% | -58.16% | |||
| EPS Basic | 96.33% | -84.74% | |||
| Normalized Basic EPS | 88.11% | -73.56% | |||
| EPS Diluted | 96.33% | -84.74% | |||
| Normalized Diluted EPS | 87.78% | -73.58% | |||
| Average Basic Shares Outstanding | 0.21% | 1.02% | |||
| Average Diluted Shares Outstanding | 0.48% | 1.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||